Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
Clinical trial NCT04222335 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04222335
- Sponsor
- University Hospital, Toulouse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-26
- Primary completion
- 2028-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.